Cargando…
Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer
PURPOSE: An effective biomarker for the diagnosis of breast cancer (BC) and benign breast diseases (BBD) is crucial for improving the prognosis. We investigated whether N6-methyladenosine (m(6)A) can be a diagnostic biomarker of BC. MATERIALS AND METHODS: We detected the contents of peripheral blood...
Autores principales: | Xiao, Han, Fan, Xiaobo, Zhang, Rui, Wu, Guoqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053864/ https://www.ncbi.nlm.nih.gov/pubmed/33138349 http://dx.doi.org/10.4143/crt.2020.870 |
Ejemplares similares
-
Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma
por: Pei, Yuqing, et al.
Publicado: (2020) -
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
por: Ye, Fei, et al.
Publicado: (2021) -
Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease
por: Hui, Yuan, et al.
Publicado: (2023) -
Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for Colorectal Cancer
por: Xie, Jinye, et al.
Publicado: (2021) -
Prognostic implications of N(6)-methyladenosine RNA regulators in breast cancer
por: Tai, Jiaojiao, et al.
Publicado: (2022)